TD Asset Management
DPLO

TD Asset Management’s DIPLOMAT PHARMACY, INC. DPLO Stock Holding History

TD Asset Management’s Portfolio DPLO Stock Details DPLO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-15,298
Closed -$193K – 1436
2016
Q4 		$193K Sell
15,298
-38,902
-72% -$725K ﹤0.01% 1346
2016
Q3 		$1.52M Sell
54,200
-22,600
-29% -$758K ﹤0.01% 924
2016
Q2 		$2.69M Sell
76,800
-1,500
-2% -$47.2K ﹤0.01% 803
2016
Q1 		$2.15M Sell
78,300
-300
-0.4% -$8.83K ﹤0.01% 831
2015
Q4 		$2.69M Buy
78,600
+300
+0.4% +$9.36K 0.01% 785
2015
Q3 		$2.25M Sell
78,300
-500
-0.6% -$21.4K ﹤0.01% 795
2015
Q2 		$3.53M Buy
78,800
+40,900
+108% +$1.54M 0.01% 771
2015
Q1 		$1.31M Buy
37,900
+7,700
+25% +$210K ﹤0.01% 897
2014
Q4 		$827K Buy
+30,200
New +$733K ﹤0.01% 975

Other funds holding DPLO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
FCM
Frontier Capital Management Boston, Massachusetts $9.73B AUM 55.65% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
HIM
Hermes Investment Management London Uk, United Kingdom $7.52B AUM 20.67% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
DSA
Davis Selected Advisers Tucson, Arizona $21.8B AUM 23.45% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

TD Asset Management's DPLO Position: Q1 2017 in Review

TD Asset Management sold out of DIPLOMAT PHARMACY, INC. (DPLO) in Q1 2017, closing a stake of 15,298 shares — an estimated $193K sold.

TD Asset Management first reported a position in DPLO in Q4 2014 and held it in 9 quarters. The position peaked at $3.53M in Q2 2015. 155 funds tracked by Wall St. Rank hold DPLO as of Q1 2017.

  • TD Asset Management reported no remaining DIPLOMAT PHARMACY, INC. position as of Q1 2017 after selling out during the quarter.
  • TD Asset Management sold 15,298 DIPLOMAT PHARMACY, INC. shares in Q1 2017, an estimated $193K.
  • TD Asset Management first reported a position in DIPLOMAT PHARMACY, INC. in Q4 2014 and held it in 9 quarters.
  • TD Asset Management's DIPLOMAT PHARMACY, INC. position peaked at $3.53M in Q2 2015.
  • 155 funds tracked by Wall St. Rank held DIPLOMAT PHARMACY, INC. as of Q1 2017.

Based on TD Asset Management's 13F filing for Q1 2017, filed 5 May 2017.